Phastar Scoops Multiple Finalist Positions in 2025 SCRIP Awards

Phastar, a global specialist biometrics & data science Contract Research Organization (CRO), has been named as finalists in two categories at the prestigious 2025 SCRIP Awards.

Symeres appoints Gabriella Gentile as Chief Operating Officer to drive transatlantic growth

STEM, Inizio Advisory Launches STEM AI to Deliver Intelligent, Data-Led HCP Interactions

XenoSTART and Minerva Imaging Expand Partnership to Deliver Integrated PDX-Radiopharmaceutical Drug Development Platform

Expanded partnership positions XenoSTART and Minerva Imaging at the forefront of radiopharmaceuticals — one of the fastest-growing areas in oncology drug development.

Transforming Drug Target Discovery, Insilico Medicine Publishes Landmark Paper Introducing AI-empowered Target Identification Pro (TargetPro) and TargetBench 1.0

- Insilico published a new study unveiling Target Identification Pro (TargetPro), a superior disease-specific model, and TargetBench 1.0, the first standardized benchmarking framework for target discovery. - TargetPro achieved 71.6% retrieval of known clinical targets, a 2–3x improvement over large language models (LLMs) such as GPT-4o, Grok3, DeepSeek-R1, Claude-Opus-4, BioGPT, and public platforms like Open Targets. - TargetPro’s predicted novel targets demonstrated 95.7% structure availability, 86.5% druggability, and 46% repurposing potential, outperforming competing systems on all measures. - TargetBench’s explainable AI models revealed disease-specific feature importance patterns, emphasizing the value of disease-specific target identification models. - New gold standard approaches improve accuracy, reliability, and transparency in AI-driven drug discovery.

Advarra’s site-sponsor consortium publishes industry report and master mutual CDA template to streamline feasibility and reduce study startup timelines

Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced the Site-Sponsor Consortium’s first industry deliverable designed to streamline a common bottleneck in clinical trials: the Confidential Disclosure Agreement (CDA).

KROHNE Introduces OPTIWAVE 1530 & 1560 Radar Level Transmitters

Quantabio Advances Newborn Screening and Emerging Applications by Streamlining DNA Extraction from Dried Blood Spot Samples

Quantabio has launched the sparQ Lysis Kit, a flexible solution that delivers high-quality, double-stranded genomic DNA from DBS punches in under 50 minutes.

Ambience Healthcare Becomes First Ambient AI Platform to Launch Inpatient CDI at the Point of Care, Built on OpenAI

OptymEdge hires Senior Director to Drive Global Roll-Out of ACUVERA Platform

Oklahoma’s Largest Locally Owned Health Plan Selects 1upHealth as a Strategic Interoperability Partner

Clearwater Receives Strategic Growth Investment from Sunstone Partners

ZeOmega Named Leader in Everest Group’s PEAK® Matrix Assessment for Second Consecutive Year

Symbiosis Expands Sterile Manufacturing Capacity with Fill/Finish Line Qualification 

P&C Labs Achieves Immediate Efficiency Gains with Proscia’s Software

Pathologists readily embrace the shift to digital workflows.

Hovione and Microinnova partner to advance modular flow chemistry for multi-purpose manufacturing

Proscia to Expand Pathology AI Capabilities with Virtual Staining

Delivering a menu of H&E, IHC, and special stains on the Concentriq platform

Ambience Healthcare Launches Real-Time HCC Compliance Validator to Reduce Audit Risk and Strengthen Documentation Integrity

Takara Bio Europe Launches Cellartis® MSC EV Wonder™, a Defined, Xeno-Free Medium for High-Yield EV Production

Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder.

PubHive Introduces Generative AI Usage Dashboard to Advance Governance and Cost Efficiency in Life Sciences

PubHive launches Generative AI Usage Dashboard to give life sciences teams visibility, compliance, and cost control for responsible AI adoption.